100 Questions & Answers about Triple Negative Breast Cancer

Approximately10-20% of breast cancer patients are diagnosed with triple-negative breast cancer. 100 Questions & Answers About Triple Negative Breast Cancer provides authoritative and practical answers to the most common questions asked by patients and their loved ones. This easy-to-read book is a comprehensive guide to the basics of triple negative breast cancer, risk factors and prevention, diagnosis, treatment, survivorship, and life after diagnosis. Written by renowned medical experts on the topic, 100 Questions & Answers About Triple Negative Breast Cancer is an invaluable resource for anyone coping with the physical and emotional turmoil of this challenging type of breast cancer.

'Carey K. Anders, MD is a clinician-scientist and an Assistant Professor of Medicine at the University of North Carolina (UNC) School of Medicine, a member of both the UNC Lineberger Comprehensive Cancer Center and the UNC Breast Center.' Her clinical efforts are devoted to the care of women with breast cancer, particularly those who are young at diagnosis and those who develop central nervous system recurrence.' She is a translational researcher who designs both laboratory experiments and clinical trials to more effectively treat women with advanced triple negative breast cancer.' She is a member of the American Society of Clinical Oncology (ASCO), American Association of Cancer Research (AACR), Translational Breast Cancer Research Consortium (TBCRC), North American Breast Cancer Group-Breast International Group (NABCG-BIG) Metastatic Working Group, and the LIVESTRONG Young Adult Alliance.' She has received honors and awards for her dedication to the practice of medicine and is well-published in the arena of breast cancer.

'Nancy U. Lin, MD Dr. Lin is a medical oncologist at Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School.''She received her undergraduate degree from Stanford University and her MD from Harvard Medical School.''Dr. Lin'trained in'Internal Medicine at Brigham & Women's Hospital and then went on to complete fellowships in hematology and medical oncology at Dana-Farber/Partners Cancer Care.' In 2005, she joined the faculty of the Women's Cancer Program at Dana-Farber where she divides her time between patient care and clinical research.''Dr. Lin's clinical and research focus is in expanding treatment options for patients with breast cancer.'